Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation [Original Articles]

Conclusions:
The number of patients with HCM in need of HT is increasing. Although post-transplant survival in HCM is excellent, waitlist mortality is substantial and with minimal decline in the most recent era, despite the frequent use of listing status upgrade by exception in this patient cohort. Different strategies to improve the performance of the organ allocation system in patients with HCM are needed.

Source: Circulation: Heart Failure - March 16, 2018 Category: Cardiology Authors: Zuniga Cisneros, J., Stehlik, J., Selzman, C. H., Drakos, S. G., McKellar, S. H., Wever-Pinzon, O. Tags: Risk Factors, Cardiomyopathy, Heart Failure, Transplantation, Mortality/Survival Original Articles Source Type: research